U.S. Stocks Tumble Amid Escalating Trade Tensions, IMF Economic Warnings, and Fed Rate Cut Expectations
U.S. stock markets extended their fall today, with the Dow Jones Industrial Average dropping 375.08 points, or 0.81 percent, to […]
[BrokerRatings]Analyst Ratings: Biotech and Financials Lead Strong Buy Momentum
Biotech and Financial Services sectors lead with strong analyst conviction, seeing numerous "Strong Buy" ratings for stocks like KPTI, ABVX,
[Earnings]Upcoming Earnings: Financials Dominate Early Week, Tech and Industrials Surge Next Tuesday
Next week's earnings calendar is heavily weighted towards financials in the early days, with major institutions like JPMorgan Chase &
[EconCal]Economic Calendar: High-Impact Events This Week
High volatility expected today, Tuesday, with Fed Chair Powell's speech at 12:20 PM EST, highly scrutinized for rate cut signals
EU Considers Mandatory Tech Sharing from Chinese Investors, Ukraine Awaits “Big” Weapons Announcements
The European Union is poised to introduce stringent measures targeting foreign direct investment, with a particular focus on Chinese companies.
[DowJonesToday]Dow Jones Navigates Trade Tensions, Posts Gains on October 14, 2025
The Dow Jones Industrial Average (^DJI) was up 587.98 points (1.29%) today, reaching 46067.58. This upward movement occurred despite renewed
U.S. Stock Futures Decline Amid Renewed China Trade Tensions and Kicking Off Q3 Earnings
U.S. stock futures are pointing lower on Tuesday, October 14, 2025, as renewed trade tensions between the United States and
US Pre-Market Futures Decline Amid Mixed Bank Earnings; Egypt Unveils $5.7 Billion Oil Exploration Plan
Key Takeaways US pre-market indices are showing declines, with S&P 500 futures (ES) down 0.9%, Nasdaq 100 futures (NQ) down
Goldman Sachs, Albertsons Report Strong Earnings; China Sanctions Escalate Trade Tensions
Key Takeaways Goldman Sachs (GS) delivered a robust Q3 2025 performance, significantly surpassing analyst expectations with adjusted EPS of $12.25
Financial Markets React to JPMorgan Earnings, Pfizer’s Breast Cancer Breakthrough, and Global Developments
Key Takeaways JPMorgan Chase & Co. (JPM) reported robust Q3 2025 adjusted revenue of $47.12 billion, exceeding analyst expectations, but